[1] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[2] |
SU Xin, FAN Wenyi, XU Xinye, XU Xuedong.
Analysis of risk factors and attributable disease burden of four major chronic diseases including cancer in the Chinese population
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 442-447.
|
[3] |
LI Shuimei, XU Sujuan, YIN Hai, ZHONG Yanmei, LIU Yingying, LIANG Jingyan.
Machine learning-based analysis of risk factors for postoperative facial paralysis in patients with parotid tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 481-486.
|
[4] |
ZHOU Yufei, LI Kaiguo, YANG Xiaohui, CHEN Xuxia, CHEN Weiling, QU Song.
Effects of LGR4 on proliferation,apoptosis,invasion,migration and epithelial mesenchymal transformation of nasopharyngeal carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 525-532.
|
[5] |
CHEN Xuxia, YANG Xiaohui, CHEN Weiling, ZHOU Yufei, LI Kaiguo, QU Song.
Overexpression of nuclear apoptosis-inducing factor 1 enhances the radiosensitivity of nasopharyngeal carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 272-277.
|
[6] |
QIN Yuelan, SUN Yongchu, CHEN Kaihua, SONG Yangguang, .
Effects of IFIT3 on invasion,metastasis and EMT of nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 143-148.
|
[7] |
SONG Yangguang, SUN Yongchu, QIN Yuelan, CHEN Kaihua, LAI Lin, CHEN Xishan, ZHU Xiaodong.
Overexpressing miR⁃486⁃5p enhanced radiosensitivity of radioresistant nasopharyngeal carcinoma cell line CNE⁃2R
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 11-17.
|
[8] |
HUANG Yujuan , DENG Yayan, LIU Xue , CHEN Yong, LI Qiuyun, YE Jiaxiang, ZHANG Jinyan, LI Yongqiang .
Regulation of EBV⁃miR⁃BART17⁃5p on proliferation and migration of nasopharyngeal #br#
carcinoma cells and its mechanism#br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 25-30.
|
[9] |
XU Yongrong, YANG Li, MA Lingxia, HUANG Xia, GAN Jiemei.
Analysis of the mediating effect of self⁃representation in alexithymia and fear of disease progression in patients with nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 70-74.
|
[10] |
QIU Liyan, YANG Li.
Application value of internet-based continuous management for nasopharyngeal carcinoma patients with symptoms 5 years after hospital discharge
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(3): 314-319.
|
[11] |
ZHAO Liyang, CUI Ling, ZHANG Ying, WANG Ling, LI Huizheng.
Regulation of the malignant biological behavior of nasopharyngeal carcinoma cells by lncRNA PRNCR1
targeting miR⁃653⁃5p
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(4): 400-406.
|
[12] |
XU Huifang, CHEN Qiong, LIU Yin, LIU Shuzheng, GUO Lanwei, ZHENG Liyang, KANG Ruihua, ZHANG Shaokai .
Analysis of incidence and mortality of nasopharyngeal carcinoma in Henan Province,2016
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 262-266.
|
[13] |
LI Lu, XU Peng, LAI Xin, QI Yunxiang, FAN Ming, ZHANG Peng, LI Bosen, LI Churong, MA Daiyuan, FENG Mei.
A prospective,one-arm,multicenter phase Ⅱ clinical study of apatinib in maintenance therapy after chemoradiotherapy
for metastatic nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 397-402.
|
[14] |
YANG Xiaohui, LI Kaiguo, ZHU Xiaodong, LI Ling, DU Youqin, YANG Liu, QU Song.
Effect of miR-6732-3p expression on radio-sensitivity of radio-resistant nasopharyngeal carcinoma cell line CNE-2R
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 403-408.
|
[15] |
ZHAO Wei, ZHANG Huaying, LAI Hao, LIN Yuan.
Relationship between nutritional status and prognosis of patients with nasopharyngeal carcinoma with concurrent chemoradiotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 409-414.
|